1. Targeting RAF dimers in RAS mutant tumors: From biology to clinic
   Huanhuan Yin et al, 2024, Acta Pharmaceutica Sinica B CrossRef
2. Case report: Venetoclax plus Azacitidine in treatment of acute undifferentiated leukemia
   Yu Cui et al, 2024, Hematology CrossRef
3. Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling
   Mehdi Mirzaie et al, 2024, Oncogenesis CrossRef
4. RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
   Yinliang Bai et al, 2024, European Journal of Medicinal Chemistry CrossRef